DUBLIN–(BUSINESS WIRE)–The “US Digital Health Market (by Technology & Component): Insights & Forecast (2024-2028)” report has been added to ResearchAndMarkets.com’s offering.
The U.S. digital health market is predicted to reach US$396.75 billion in 2028, progressing at a CAGR of 28.4%, over the period 2024-2028.
The factors such as increasing geriatric population, growing usage of mobile devices, surging prevalence of arthritis, hike in healthcare expenditure, expanding urbanization and mounting penetration of internet users would drive the growth of the market. However, the market growth would be challenged by high capital cost and installations, lack of interoperability and data breach and security concerns. A few notable trends include upsurge in the number of healthcare apps, surging occurrence of chronic diseases, escalating penetration of electronic health record (EHR) systems and increasing importance of wearable devices.
The U.S. digital health market has been segmented on the basis of technology and component. In terms of technology, the U.S. digital health market can be bifurcated into mHealth, digital health systems, health analytics and tele healthcare. Whereas, the market can be split into services, hardware and software, on the basis of component.
The mHealth segment is the fastest growing market, owing to rapid digitalization, mounting occurrence of chronic diseases such as cardiovascular diseases and diabetes in the region, various technological advancements in the healthcare industry coupled with recent advancements in wearable technologies and high internet usage. In addition, the growing number of COVID-19 cases across the region in 2020, escalated the adoption of digital health solutions to maintain social distancing and to improve the communication between patients and healthcare professionals during the pandemic.
Scope of the report
Key Attributes:
Report Attribute | Details |
No. of Pages | 71 |
Forecast Period | 2024 – 2028 |
Estimated Market Value (USD) in 2024 | $145.97 Billion |
Forecasted Market Value (USD) by 2028 | $396.75 Billion |
Compound Annual Growth Rate | 28.4% |
Regions Covered | United States |
Key Topics Covered:
1. Market Overview
1.1 Introduction
1.2 Global Evolution of Digital Health
1.3 Classification of Digital Health
1.4 Essential Components of Digital Health
1.5 Benefits of Digital Health Technologies
1.6 Technologies Involved in Digital Healthcare
1.7 Digital Health Tools
2. Impact of COVID-19
2.1 Demand Surge for Digital Health Solutions
2.2 Surging Adoption of Telemedicine
2.3 Rising Depression Rate
3. The U.S. Market Analysis
3.1 The U.S. Digital Health Market by Value
3.2 The U.S. Digital Health Market Forecast by Value
3.3 The U.S. Digital Health Market by Technology
3.4 The U.S. Digital Health Market by Component
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Geriatric Population
4.1.2 Growing Usage of Mobile Devices
4.1.3 Surging Prevalence of Arthritis
4.1.4 Hike in Healthcare Expenditure
4.1.5 Expanding Urbanization
4.1.6 Surging Occurrence of Chronic Diseases
4.1.7 Mounting Penetration of Internet Users
4.2 Key Trends & Developments
4.2.1 Upsurge in the Number of Healthcare Apps
4.2.2 Escalating Penetration of Electronic Health Record (EHR) Systems
4.2.3 Increasing Importance of Wearable Devices
4.2.4 Rising Integration with Artificial Intelligence
4.2.5 Surging Adoption of SaaS Applications
4.2.6 Supportive Government Initiatives
4.3 Challenges
4.3.1 High Capital Cost and Installations
4.3.2 Lack of Interoperability
4.3.3 Data Breach and Security Concerns
5. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/p2ogzg
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (“Masimo” or the “Company”) (NASDAQ: MASI), a global leader in noninvasive…
Media ReleaseCOPENHAGEN, Denmark; September 15, 2024 Treatment with rinatabart sesutecan (Rina-S) showed encouraging response rate…
Trial investigating Cabometyx® (cabozantinib) in combination with atezolizumab demonstrated a positive trend towards improvement for…
RIYADH, Saudi Arabia, Sept. 15, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research…
Prostate-specific membrane antigen (PSMA) is a leading target for next-generation prostate cancer therapies, with one…
23ME-00610 monotherapy demonstrates preliminary evidence of clinical benefit in clear-cell renal-cell carcinoma, with one confirmed…